Ppd Development Lp
UEI ZANENSW6C665 · NC · subsidiary of Ppd Development Lp · SAM.gov record ↗
Obligations by agency
- Department Of Health And Human Services$32.6M
- General Services Administration$3K
- Department Of Defense$-53K
Obligations by NAICS
Monthly obligations
Contracts ending within 18 months (recompete watch)
- 75N93022C00001 ↗$5.8M
REGULATORY MANAGEMENT CENTER (RMC)
- Ends
- Oct 30, 2026
- Started
- Oct 31, 2021
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75N93026F00001 ↗$3.1M
DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)
- Ends
- Dec 13, 2026
- Started
- Dec 14, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75N93022F00001 ↗$367K
TASK AREA A: ADMINISTRATION AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT
- Ends
- Jan 12, 2027
- Started
- Jan 13, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93024F00001 ↗$49.5M
NIAID CLINICAL SITE MONITORING (NCSM)
- Ends
- Jan 30, 2027
- Started
- Jan 31, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75N98026F00001 ↗$116K
TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT
- Ends
- Apr 27, 2027
- Started
- Jun 28, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N93022C00014 ↗$14.5M
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)
- Ends
- Jun 28, 2027
- Started
- Jun 29, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541715
FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE
- Ends
- Jul 14, 2027
- Started
- Sep 10, 2024
- Agency
- Food And Drug Administration
- NAICS
- 541714
- 75F40124C00134 ↗$802K
MOD P00001 - TO CHANGE CONTRACT TYPE FOR BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.
- Ends
- Nov 21, 2027
- Started
- Sep 23, 2024
- Agency
- Food And Drug Administration
- NAICS
- 541720
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93022C00001 ↗ | REGULATORY MANAGEMENT CENTER (RMC) | National Institutes Of Health | 541714 | $5.8M | Oct 31, 2021 | Oct 30, 2026 |
| 75N93026F00001 ↗ | DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX) | National Institutes Of Health | 541714 | $3.1M | Dec 14, 2025 | Dec 13, 2026 |
| 75N93022F00001 ↗ | TASK AREA A: ADMINISTRATION AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT | National Institutes Of Health | 541715 | $367K | Jan 13, 2022 | Jan 12, 2027 |
| 75N93024F00001 ↗ | NIAID CLINICAL SITE MONITORING (NCSM) | National Institutes Of Health | 541714 | $49.5M | Jan 31, 2024 | Jan 30, 2027 |
| 75N98026F00001 ↗ | TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT | National Institutes Of Health | 541712 | $116K | Jun 28, 2026 | Apr 27, 2027 |
| 75N93022C00014 ↗ | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC) | National Institutes Of Health | 541715 | $14.5M | Jun 29, 2022 | Jun 28, 2027 |
| 75F40124C00117 ↗ | FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE | Food And Drug Administration | 541714 | $0 | Sep 10, 2024 | Jul 14, 2027 |
| 75F40124C00134 ↗ | MOD P00001 - TO CHANGE CONTRACT TYPE FOR BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS. | Food And Drug Administration | 541720 | $802K | Sep 23, 2024 | Nov 21, 2027 |
Largest awards
- 75N93024F00001 ↗$49.5M
NIAID CLINICAL SITE MONITORING (NCSM)
- Ends
- Jan 30, 2027
- Started
- Jan 31, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75N93022C00014 ↗$14.5M
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)
- Ends
- Jun 28, 2027
- Started
- Jun 29, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93024F00002 ↗$8.7M
EOI::RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL
- Ends
- Aug 13, 2026
- Started
- Aug 14, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75N93022C00001 ↗$5.8M
REGULATORY MANAGEMENT CENTER (RMC)
- Ends
- Oct 30, 2026
- Started
- Oct 31, 2021
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75N93026F00001 ↗$3.1M
DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)
- Ends
- Dec 13, 2026
- Started
- Dec 14, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541714
- 75N93019F00131 ↗$892K
DAIDS ONSITE MONITORING FOR 1 PHASE III STUDY: A5300B/PHOENIX
- Ends
- Dec 13, 2025
- Started
- Apr 14, 2019
- Agency
- National Institutes Of Health
- NAICS
- 541711
- 75F40124C00134 ↗$802K
MOD P00001 - TO CHANGE CONTRACT TYPE FOR BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.
- Ends
- Nov 21, 2027
- Started
- Sep 23, 2024
- Agency
- Food And Drug Administration
- NAICS
- 541720
- 75N93022F00001 ↗$367K
TASK AREA A: ADMINISTRATION AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT
- Ends
- Jan 12, 2027
- Started
- Jan 13, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N95024F00001 ↗$302K
RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029.
- Ends
- Jun 15, 2029
- Started
- Jun 16, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N95024F00001 ↗$185K
CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. REGULATORY PATHWAY AND MARKET ACCESS SUPPORT. TASK ORDER 03. 04/09/2024 - 04/08/2029.
- Ends
- Apr 7, 2029
- Started
- Apr 8, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N98026F00001 ↗$116K
TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT
- Ends
- Apr 27, 2027
- Started
- Jun 28, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541712
TASK ORDER75N95025F00001 TO4 BLUEPRINT MEDTECH PREPARATION OF PRE-SUBMISSION SUPPORT FOR PILOT PARTICIPANT.
- Ends
- Dec 18, 2025
- Started
- Dec 19, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541715
ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC)
- Ends
- —
- Started
- Dec 16, 2024
- Agency
- Federal Acquisition Service
- NAICS
- 541690
OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT
- Ends
- —
- Started
- Jun 19, 2022
- Agency
- Defense Health Agency
- NAICS
- 541714
EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TERMINATION FOR CONVENIENCE. CLINICAL RESEARCH AND STUDY MONITORING SUPPORT FOR NIMH STUDIES
- Ends
- May 14, 2025
- Started
- Sep 27, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541990
EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI
- Ends
- Jan 30, 2026
- Started
- Jun 28, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541715
SAHN SINGLE ASCENDING DOSE (SAD) PHASE I STUDY (4ET1103)
- Ends
- Jun 29, 2026
- Started
- Jul 7, 2016
- Agency
- National Institutes Of Health
- NAICS
- 541712
FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE
- Ends
- Jul 14, 2027
- Started
- Sep 10, 2024
- Agency
- Food And Drug Administration
- NAICS
- 541714
THE PURPOSE OF THIS MODIFICATION IS TO: 1. UPDATE SECTION G.1 OF THE CONTRACT TO CHANGE THE CONTRACTING OFFICER TO JILL JOHNSON. TALL OTHER TERMS AND CONDITIONS REMAIN THE SAME.
- Ends
- Sep 27, 2029
- Started
- Sep 28, 2023
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541715
BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC CANDIDATES IN HOSPITALIZED ADULTS WITH ARDS.
- Ends
- Sep 29, 2030
- Started
- Dec 14, 2023
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541714
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS
- Ends
- —
- Started
- Aug 31, 2021
- Agency
- National Institutes Of Health
- NAICS
- 541714
EARLY PHASE CLINICAL TRIAL UNITS (EPCTU)
- Ends
- —
- Started
- Jan 13, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541715
CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. ORDERING PERIOD: 9/22/2022 - 9/21/2027. N02DA-22-1235.
- Ends
- —
- Started
- Sep 21, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541715
RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. ORDERING PERIOD: 09/01/2023 - 8/31/2028. (BPMT) INITIATIVE.
- Ends
- —
- Started
- Aug 31, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541715
- HHSN272201200002C ↗$-338
REGULATORY MANAGEMENT CENTER
- Ends
- Oct 30, 2021
- Started
- Oct 31, 2011
- Agency
- National Institutes Of Health
- NAICS
- 541711
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93024F00001 ↗ | NIAID CLINICAL SITE MONITORING (NCSM) | National Institutes Of Health | 541714 | $49.5M | Jan 31, 2024 | Jan 30, 2027 |
| 75N93022C00014 ↗ | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC) | National Institutes Of Health | 541715 | $14.5M | Jun 29, 2022 | Jun 28, 2027 |
| 75N93024F00002 ↗ | EOI::RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL | National Institutes Of Health | 541714 | $8.7M | Aug 14, 2024 | Aug 13, 2026 |
| 75N93022C00001 ↗ | REGULATORY MANAGEMENT CENTER (RMC) | National Institutes Of Health | 541714 | $5.8M | Oct 31, 2021 | Oct 30, 2026 |
| 75N93026F00001 ↗ | DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX) | National Institutes Of Health | 541714 | $3.1M | Dec 14, 2025 | Dec 13, 2026 |
| 75N93019F00131 ↗ | DAIDS ONSITE MONITORING FOR 1 PHASE III STUDY: A5300B/PHOENIX | National Institutes Of Health | 541711 | $892K | Apr 14, 2019 | Dec 13, 2025 |
| 75F40124C00134 ↗ | MOD P00001 - TO CHANGE CONTRACT TYPE FOR BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS. | Food And Drug Administration | 541720 | $802K | Sep 23, 2024 | Nov 21, 2027 |
| 75N93022F00001 ↗ | TASK AREA A: ADMINISTRATION AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT | National Institutes Of Health | 541715 | $367K | Jan 13, 2022 | Jan 12, 2027 |
| 75N95024F00001 ↗ | RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029. | National Institutes Of Health | 541715 | $302K | Jun 16, 2024 | Jun 15, 2029 |
| 75N95024F00001 ↗ | CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. REGULATORY PATHWAY AND MARKET ACCESS SUPPORT. TASK ORDER 03. 04/09/2024 - 04/08/2029. | National Institutes Of Health | 541715 | $185K | Apr 8, 2024 | Apr 7, 2029 |
| 75N98026F00001 ↗ | TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT | National Institutes Of Health | 541712 | $116K | Jun 28, 2026 | Apr 27, 2027 |
| 75N95025F00001 ↗ | TASK ORDER75N95025F00001 TO4 BLUEPRINT MEDTECH PREPARATION OF PRE-SUBMISSION SUPPORT FOR PILOT PARTICIPANT. | National Institutes Of Health | 541715 | $5K | Dec 19, 2024 | Dec 18, 2025 |
| 47QRCA25DU259 ↗ | ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC) | Federal Acquisition Service | 541690 | $3K | Dec 16, 2024 | — |
| HT001122D0040 ↗ | OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT | Defense Health Agency | 541714 | $0 | Jun 19, 2022 | — |
| 75N95022C00036 ↗ | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TERMINATION FOR CONVENIENCE. CLINICAL RESEARCH AND STUDY MONITORING SUPPORT FOR NIMH STUDIES | National Institutes Of Health | 541990 | $0 | Sep 27, 2022 | May 14, 2025 |
| 75N93023F00001 ↗ | EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI | National Institutes Of Health | 541715 | $0 | Jun 28, 2023 | Jan 30, 2026 |
| 75N95024F00001 ↗ | SAHN SINGLE ASCENDING DOSE (SAD) PHASE I STUDY (4ET1103) | National Institutes Of Health | 541712 | $0 | Jul 7, 2016 | Jun 29, 2026 |
| 75F40124C00117 ↗ | FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE | Food And Drug Administration | 541714 | $0 | Sep 10, 2024 | Jul 14, 2027 |
| 75A50123C00045 ↗ | THE PURPOSE OF THIS MODIFICATION IS TO: 1. UPDATE SECTION G.1 OF THE CONTRACT TO CHANGE THE CONTRACTING OFFICER TO JILL JOHNSON. TALL OTHER TERMS AND CONDITIONS REMAIN THE SAME. | Office Of Assistant Secretary For Preparedness And Response | 541715 | $0 | Sep 28, 2023 | Sep 27, 2029 |
| 75A50124C00001 ↗ | BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC CANDIDATES IN HOSPITALIZED ADULTS WITH ARDS. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Dec 14, 2023 | Sep 29, 2030 |
| 75N93021D00035 ↗ | COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS | National Institutes Of Health | 541714 | $0 | Aug 31, 2021 | — |
| 75N93022D00017 ↗ | EARLY PHASE CLINICAL TRIAL UNITS (EPCTU) | National Institutes Of Health | 541715 | $0 | Jan 13, 2022 | — |
| 75N95022D00020 ↗ | CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. ORDERING PERIOD: 9/22/2022 - 9/21/2027. N02DA-22-1235. | National Institutes Of Health | 541715 | $0 | Sep 21, 2022 | — |
| 75N95023D00011 ↗ | RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. ORDERING PERIOD: 09/01/2023 - 8/31/2028. (BPMT) INITIATIVE. | National Institutes Of Health | 541715 | $0 | Aug 31, 2023 | — |
| HHSN272201200002C ↗ | REGULATORY MANAGEMENT CENTER | National Institutes Of Health | 541711 | $-338 | Oct 31, 2011 | Oct 30, 2021 |